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Abstract 
BACKGROUND:  
General skin care recommendations such as the use of moisturisers and products with adequate 
photoprotection are important components of management for acne patients to complement the 
medical regimen. This study aimed to evaluate the real-life clinical effects of a novel UV-selective 
face cream (Acne RA-1,2) on acne, epidermal barrier function, sebum production, adherence and 
tolerability when used together with pharmacological acne treatment. 
METHODS:  
40 patients receiving pharmacological acne treatment applied Acne RA- 1,2 once-daily for 3 
months. Investigator's Global Assessment of acne, trans- epidermal water loss, sebum production 
and tolerability were assessed after 1 and 3 months. 
RESULTS:  
After 3 months, there was a 38% significant clinical improvement in mean Investigator Global 
Assessment score (3.4 to 2.1), a 29% significant reduction in trans-epidermal water loss (13.2 to 9.4 
g/h/m2), and a 17% significant decrease in sebum production vs baseline (234.6 to 195.6 μg/cm2; 
all p<0.01). 100% of patients reported complete adherence to pharmacological therapy over the 
summer of the study vs 52.5% in the previous summer. 87.5% considered their acne improved over 
the summer of the study vs 55.0% in the previous summer. Pruritus, erythema, dryness and total 
tolerability symptom scores were significantly reduced after 3 months vs baseline (p<0.05). 
CONCLUSIONS:  
Acne RA-1,2 is a useful daily adjunct to pharmacological therapy as it helps to mitigate the 
irritation these therapies cause, increasing adherence to therapy, and leading to a clinical 
improvement in acne and epidermal barrier function and a decrease in sebum production. 
 
